Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: A single center study

Indian Journal of Nephrology

Volumn 20, Issue 3, 2010, Pages 132-136

  Agarwal, S K ^a   Gupta, S ^a   Bhowmik, D ^a   Mahajan, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Latent tuberculosis; renal replacement therapy; tuberculin test

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TUBERCULIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDEMIC DISEASE; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; SEX; TUBERCULIN TEST;

EID: 77958050035     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.70842     Document Type: Article

References (30)

1. Sasaki S, Akiba T, Suenaga M, Tomura S, Yoshiyama N, Nakagawa S, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron 1979;24:141-5.
2. Belcon MC, Smith EK, Kahana LM, Shimizu AG: Tuberculosis in dialysis patients. Clin Nephrol 1982;17:14-8.
3. Garcia-Leoni ME, Martin-Scapa C, Rodeno P, Valderrabano F, Moreno S, Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990;9:283-5.
4. Malhotra KK, Parashar MK, Sharma RK, Bhuyan UN, Dash SC, Kumar R, et al. Tuberculosis in maintenance haemodialysis patients: Study from an endemic area. Postgrad Med J 1981;57:492-8.
5. Agarwal SK. Tuberculosis in Chronic Renal Failure. In: Sharma SK, Mohan A, editors. Tuberculosis. Delhi: Jaypee Brothers; 2001. p. 338-47.
6. Touraine JL, Touraine F, Revillard JP, Brochier J, Traeger J. T-lymphocytes and serum inhibitors of cell mediated immunity in renal insuffciency. Nephron 1975;14:195-208.
7. Rutsky EA, Rostand SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med 1980;140:57-61.
8. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
9. Agarwal SK, Dash SC, Irshad M, Gupta S, Bhowmik D, Tiwari SC, et al. Impact of hepatitis C virus infection on renal transplant outcome in India: A Single Center Study. J Assoc Physicians India 2000;48:1155-9.
10. Essential Components of a tuberculosis prevention and control program: Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995;44:1-16.
11. Targeted tuberculin testing and treatment of latent tuberculosis infection: This offcial statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999: This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC): This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161:S221-47.
12. Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004;36:425-31.
13. Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis 2005;7:99-108.
14. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998;113:25-7.
15. Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998;31:848-52.
16. Akcay A, Erdem Y, Altun B, Usalan C, Agca E, Yasavul U, et al. The booster phenomenon in 2-step tuberculin skin testing of patients receiving long-term hemodialysis. Am J Infect Control 2003;31:371-4.
17. Poduval RD, Hammes MD. Tuberculosis screening in dialysis patients-is the tuberculin test effective? Clin Nephrol 2003;59:436-40.
18. Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, et al. The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004;19:433-8.
19. Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005;20:2720-4.
20. Dogan E, Erkoc R, Sayarlioglu H, Uzun K. Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Ren Fail 2005;27:425-8.
21. Khosroshahi HT, Shoja EA, Beiglu LG, Hassan AP. Tuberculin testing of kidney allograft recipients and donors before transplantation. Transplant Proc 2006;38:1982-4.
22. Baolu OK, Atasever A, Gündüz Telli C, Ozol D, A?çi G, Ardeniz O, et al. T-lymphocyte subgroups and tuberculin skin test reactivity in patients with chronic renal failure. Tuberk Toraks, 2006, 54, 5-10.
23. Kantarci G, Altinöz H, Sahin S, Manga G, Ta?an G. Tuberculin positivity: A serious problem before transplantation in Turkey. Transplant Proc 2006;38:646-8.
24. Cengiz K, Seker A. Boosted tuberculin skin testing in hemodialysis patients. Am J Infect Control 2006;34:383-7.
25. Habesolu MA, Torun D, Demiroglu YZ, Karatasli M, Sen N, Ermis H, et al. Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc, 2007, 39, 883-6.
26. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007;2:68-73.
27. Edwards PQ, Edwards LB. Story of the tuberculin test from an epidemiologic viewpoint. Am Rev Respir Dis 1960:81:1-47.
28. Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, et al. Tuberculin-purifed protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immnol 1999;6;934-7.
29. Streeton JA, Desem N, Jones SL. Sensitivity and specifcity of a γ interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998;2:443-50.
30. Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NM. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: Effect of human immunodefciency virus infection. J Infect Dis 1997;176:144-50.